SCHEMBL6209919

SCHEMBL6209919

Cc1nc(-c2ccc(F)cc2F)c(Br)n1Cc1ccccc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 4/20 0.47
HK1 P19367 1/20 0.42
HTT P42858 1/20 0.42
HKDC1 Q2TB90 1/20 0.42
TNF P01375 1/20 0.42
DHFR P00374 2/20 0.40
CYP11B2 P19099 1/20 0.39
PDE9A O76083 1/20 0.39
GALR3 O60755 1/20 0.39
NR2F2 P24468 1/20 0.39
BRD4 O60885 1/20 0.38
GRM2 Q14416 1/20 0.38
ALDH1A1 P00352 3/20 0.38
KDM4E B2RXH2 3/20 0.38
GAA P10253 2/20 0.38
MAPK1 P28482 1/20 0.38
HSD17B10 Q99714 1/20 0.38
TSHR P16473 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
MAPK14 Q16539 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL989287 0.82 TNF (0.45) MAPTHK1HTTHKDC1TNF
SCHEMBL6209619 0.80 ALDH1A1 (0.42) MAPTHK1HTTHKDC1CYP11B2
SCHEMBL4830285 0.80 MAPT (0.41) MAPTHK1HTTHKDC1CYP11B2
SCHEMBL4533975 0.75 ALDH1A1 (0.39) MAPTHK1HTTHKDC1TNF
SCHEMBL990110 0.74 CYP2C19 (0.42) MAPTHK1HTTHKDC1TNF
SCHEMBL4833510 0.72 ALDH1A1 (0.43) MAPTHK1HTTHKDC1CYP11B2
SCHEMBL3522590 0.72 MAPK14 (0.56) MAPK14
SCHEMBL4836206 0.72 MAPT (0.61) MAPTHTTHKDC1TNFGALR3
SCHEMBL27007784 0.68 KMT2A (0.44) MAPTGALR3NR2F2ALDH1A1KDM4E
SCHEMBL13635178 0.65 MAPK14 (0.56) MAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1554272-A1 BENZIMIDAZOLES AND BENZOTHIAZOLES AS INHIBITORS OF MAP KINASE ELI LILLY AND COMPANY (US) 2005-07-20 EP disclosed
WO-2004014900-A1 BENZIMIDAZOLES AND BENZOTHIAZOLES AS INHIBITORS OF MAP KINASE ELI LILLY AND COMPANY (US) 2004-02-19 WO disclosed